Given its widespread functionality, abnormalities in the TGF-β signaling pathway have been found to lead to diverse human diseases such as hypertension, hyperlipidemia, atherosclerosis, renal and cardiac fibrosis, and cancer, which are in turn associated with metabolic syndrome (MetS)3–6. The gene discussed is TGFB1; the disease is metabolic syndrome.